This inventor holds 1 USPTO granted patent. Top assignee: Pliva, Inc.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Bozidar Suskovic: Innovator in Pharmaceutical Purification
Introduction
Bozidar Suskovic is a notable inventor based in Tuskanec, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of oxytetracycline. His innovative approach has led to advancements in the quality and efficacy of this important antibiotic.
Latest Patents
Bozidar Suskovic holds a patent for a process and intermediate for the purification of oxytetracycline. This invention relates to a new method for obtaining completely pure oxytetracycline, free from any acetyldecarboxamidooxytetracycline. The process involves suspending oxytetracycline hydrochloride or oxytetracycline dihydrate in glacial acetic acid, followed by the addition of an equimolar quantity of hydrogen chloride. The stirring process continues for five hours, resulting in the formation of oxytetracycline hydrochloride acetate, which is then filtered, washed, and dried. This new compound serves as an intermediate in the purification process.
Career Highlights
Bozidar Suskovic is associated with Pliva, Inc., a prominent pharmaceutical company known for its innovative drug development. His work at Pliva has allowed him to focus on enhancing pharmaceutical processes and improving drug formulations. His dedication to research and development has positioned him as a key figure in the industry.
Collaborations
One of his notable collaborators is Marija Cakara, with whom he has worked closely on various projects. Their partnership has contributed to the advancement of pharmaceutical technologies and the development of new processes.
Conclusion
Bozidar Suskovic's contributions to the field of pharmaceutical purification highlight his innovative spirit and commitment to improving drug quality. His patent for the purification of oxytetracycline represents a significant advancement in the industry. His work continues to influence the pharmaceutical landscape, ensuring better health outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile